Violation Tracker Individual Record
Company:
Shire Pharmaceuticals LLC
Current Parent Company:
Takeda Pharmaceutical
Penalty:
$6,104,000
Year:
2017
Date:
January 11, 2017
Offense Group:
government-contracting-related offenses
Primary Offense:
False Claims Act and related
Secondary Offense:
kickbacks and bribery
Violation Description:
Shire agreed to pay $6.1 million as part of the settlement of multistate litigation alleging that it and a company it acquired in 2011, Advanced BioHealing, employed kickbacks and other unlawful methods to improperly promote Dermagraft, a bioengineered human skin substitute approved by the FDA for the treatment of diabetic foot ulcers. This was part of a larger $350 million involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-shire-phar...
Level of Government:
state
Action Type:
agency action
Agency:
Multistate Attorneys General Case
Civil or Criminal Case:
civil
HQ Country of Parent:
Japan
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
